Style Editor Docs
     
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • US FDA IDE Pre-Submission
      • US FDA IDE Updates
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Investors
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
   Contact Us
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • US FDA IDE Pre-Submission
      • US FDA IDE Updates
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Investors
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
    December 29, 2022

    Dr. John E. Heidrich, PHD, VCM joins our Veterinary Medicine Advisory Board

    Dr. John E. Heidrich, Ph.D., VCM, joined our Veterinary Medicine Advisory Board, chaired by Dr. Alice Villalobos. 

     

    He recently retired as co-owner of VCA Ventana Animal Hospital in Albuquerque, NM. He brings senior practical experience in veterinary medicine and will be particularly helpful in locating patients for IsoPet® therapy. 

     

    He recently accompanied us at our booth at the 68th Annual Convention of the American Association of Equine Practitioners, AAEP, in San Antonio, Texas.

     

     

    About Dr. John E. Heidrich:

     

    He recently spent a year in Cambodia teaching veterinarians and technicians so that they could improve their medical skills.

     

    His passion is to find the best care for all animals through educating students.

     

    He has a solid surgical interest in orthopedics and the treatment of chronic pain. Besides his interest in your pet's pain management, he has been involved with studies of how diseases can be transmitted between animals and people as well as from people to animals.

     

    He has spent his working vacations over the past 15 years trapping wild cynomolgus monkeys in Nepal, Bangladesh, Thailand, Indonesia, and Cambodia.

     

    Because of his international interests, he has spearheaded the WORLDWIDE PEN PALS program, linking Albuquerque area schools with those abroad and encouraging literacy, writing, and global awareness in school children. Countries involved in this pen pal program are Cambodia, Guatemala, Tanzania, Malawi, Papua New Guinea, and more to come.

     

    Dr. Heidrich was instrumental in starting the veterinary technician program at CNM and loved having students in the clinic. We want to share with students our lifelong commitment to providing the best care as a member of your healthcare team for your pet.

    tagPlaceholderTags:

    Vivos, Inc.

    Precision Radionuclide Therapy (PRnT)

    OTCQB: RDGL

    contact: info@radiogel.com


    Home Page Cover Image: 

     

    Veterinarian Dr. Michelle Myer from Vista Veterinarian Hospital in Kennewick, WA.

     

    Seen here administering IsoPet® therapy to a feline suffering from a sarcoma.

    RadioGel™ is a hydrogel liquid containing tiny yttrium-90 (90Y)  phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

    IsoPet® Therapy Application(s)


    Precision Radionuclide Therapy (PRnT)


    Vivos Inc.
     - (OTCQB: RDGL) Investor Relations 

    Contact

     

    Main colors
       bg-primary
       bg-primary-light
       bg-primary-dark
       bg-secondary
       bg-secondary-dark
    Template sections
       body
       top-header
       header
       content
    Footer Styles
       background
       text color
       link color
       horizontal line
    Buttons
       style 1
       style 2
       style 3
    Other elements
      social icons
      navigation color
      subnav background
    Mobile navigation
       background color
       navigation color
    Template configurations
    has-right-nav g-font
    navigation styles
    size-15 weight-400 snip-nav
    content styles
    form-white
    footer styles
    o-form color-white
    Typography
    Heading H1
    weight-600
    Heading H2
    weight-600
    Heading H3
    weight-600
    Buttons
    weight-600 is-uppercase
    Animations

    Note:
    All changes made here will be applied to your entire website.
    is-switcher admin-only

    RadioGel™ Logo

    Precision Radionuclide Therapy (PRnT)

    draggable-logo

    About | Privacy Policy | Cookie Policy | Sitemap
    © 2022 Vivos Inc. | RadioGel™ is a registered trademark | IsoPet® is a registered trademark
    Log out | Edit
    • Scroll to top